Shifting serotypes, plasmid profile analysis and antimicrobial resistance pattern of shigellae strains isolated from

S Dutta1, K Rajendran, S Roy

  • 1National Institute of Cholera and Enteric Diseases, Kolkata, India.

Insights

Shigella strains in Kolkata show changing species prevalence and increasing antibiotic resistance, particularly to tetracycline, co-trimoxazole, and nalidixic acid. This highlights reduced efficacy of common treatments for shigellosis in the region.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Shigellosis remains a significant public health concern, especially in developing countries.
  • Understanding the evolving epidemiology of Shigella, including serotype distribution and antimicrobial resistance, is crucial for effective treatment and control.

Purpose of the Study:

  • To investigate the serotype prevalence, antimicrobial resistance patterns, and plasmid profiles of Shigella strains isolated from pediatric patients in Kolkata, India.
  • To identify epidemiological shifts in Shigella species and their resistance trends over a six-year period.

Main Methods:

  • Serotyping of 166 Shigella strains isolated from stool samples.
  • Antimicrobial susceptibility testing against 12 agents, including determination of minimum inhibitory concentrations (MICs).
  • Plasmid profile analysis using gel electrophoresis.

Main Results:

  • Shigella flexneri (58%) was the predominant species, a shift from previous trends where Sh. dysenteriae 1 was common.
  • High resistance rates were observed for tetracycline (>90%), co-trimoxazole (>90%), and ampicillin (67%).
  • A statistically significant increase in resistance to tetracycline, nalidixic acid, and furazolidone was noted over the study period, indicating decreased drug efficacy.

Conclusions:

  • The study reveals a changing epidemiological landscape of Shigella in Kolkata, with a rise in Sh. flexneri and increasing multidrug resistance.
  • Decreased susceptibility to furazolidone, co-trimoxazole, and nalidixic acid necessitates re-evaluation of empirical treatment guidelines for shigellosis in this region.
  • Plasmid analysis provided insights into the genetic basis of resistance and serotype distribution.